Christoph Engeler is a counsel in the Hamburg office. Mr. Engeler practices in the firm’s Corporate Department, focusing on corporate and regulatory matters in the healthcare and life science industries. He has a wealth of experience advising domestic and international hospital and nursing home operators as well as financial investors in healthcare institutions on M&A transactions and restructurings. He further advises public authorities on privatizations of healthcare institutions and joint ventures. In the life science sector, Mr. Engeler advises German and foreign pharmaceuticals companies and manufacturers of medical devices on M&A transactions and German as well as EU regulatory matters, including clinical trials, manufacturing, marketing authorizations, distribution, promotion and marketing, vigilance and reimbursement.
Mr. Engeler joined the firm in the summer of 2002. He previously worked as an associate in the corporate department of a leading international law firm in New York from 2000 through 2002. On a secondment basis he worked in the legal department of Bankhaus Metzler, Frankfurt, Germany for three months.
Mr. Engeler is a regular author of articles on corporate and healthcare law topics.